Status:
COMPLETED
Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea
Lead Sponsor:
Organon and Co
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Study to test the effectiveness of a marketed drug in the treatment of migraine-associated nausea.
Eligibility Criteria
Inclusion
- 6-month history of migraine, moderate to severe migraine attacks with nausea, 1-6 migraine attacks per month
Exclusion
- Heart disease, high blood pressure
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT00250458
Start Date
March 1 2006
End Date
October 1 2006
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.